Altered liver lipidome markedly overlaps with human plasma lipids at diabetes risk and reveals adipose-liver interaction
Journal of Lipid Research · 2025
DOI: 10.1016/j.jlr.2025.100767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2025. Verfasst von Ratika Sehgal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Resear…. Hauptthemen laut MEDLINE: Liver, Lipidomics, Adipose Tissue, Lipid Metabolism. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, Federal Ministry of Education and Research Bonn Office, Brandenburg State Ministry of Science Research and Culture.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Present study explores the role of liver lipidome in driving T2D-associated metabolic changes. Elevated liver triacylglycerols, reduced PUFAs, and 86 differentially abundant lipid species were identified in diabetes-prone mice. Of these altered lipid species, 82 markedly overlap with human plasma lipids associated with T2D/CVD risk. Pathway enrichment highlighted sphingolipid metabolism, however, only five of all genes involved in the pathway were differentially expressed in the liver. Interestingly, overlap with adipose tissue transcriptome was much higher (57 genes), pointing toward an active adipose-liver interaction. Next, the integration of liver lipidome and transcriptome identified strongly correlated lipid-gene networks highlighting ceramide [Cer(22:0)], dihydroceramide(24:1), and triacylglycerol(58:6) playing a central role in transcriptional regulation. Putative molecular targets of Cer(22:0) were altered (Cyp3a44, Tgf-β1) in primary mouse hepatocytes treated with Cer(22:0). Early alteration of liver lipidome markedly depends on adipose tissue expression pattern and provides substantial evidence linking early liver lipidome alterations and risk of T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München-Neuherberg, Germany; Division of Endocrinology and D…
- Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München-Neuherberg, Germany.
- Freie Universität Berlin, Institute of Pharmacy, Berlin, Germany.
- Department of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany; German Center for Diabetes Research (DZD), München-Neuherberg, Germany; Institute of Nutritional Scienc…
Förderung
- Horizon 2020 Framework Programme
- Federal Ministry of Education and Research Bonn Office
- Brandenburg State Ministry of Science Research and Culture
- German Research Foundation
Zitieren
APA
Sehgal, R., Jähnert, M., Lazaratos, M., Speckmann, T., Schumacher, F., Kleuser, B., Ouni, M., Jonas, W., & Schürmann, A. (2025). Altered liver lipidome markedly overlaps with human plasma lipids at diabetes risk and reveals adipose-liver interaction. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2025.100767
Vancouver
Sehgal R, Jähnert M, Lazaratos M, Speckmann T, Schumacher F, Kleuser B, et al. Altered liver lipidome markedly overlaps with human plasma lipids at diabetes risk and reveals adipose-liver interaction. Journal of Lipid Research. 2025. doi:10.1016/j.jlr.2025.100767
BibTeX
@article{Sehgal2025,
author = {Sehgal, Ratika and Jähnert, Markus and Lazaratos, Michail and Speckmann, Thilo and Schumacher, Fabian and Kleuser, Burkhard and Ouni, Meriem and Jonas, Wenke and Schürmann, Annette},
title = {Altered liver lipidome markedly overlaps with human plasma lipids at diabetes risk and reveals adipose-liver interaction},
journal = {Journal of Lipid Research},
year = {2025},
doi = {10.1016/j.jlr.2025.100767}
}
EUVIMED